Biosimilars Education: Oncobiologics/Premier Deal Aims To Boost Adoption, Data Collection

With two biosimilars set to move into Phase III this year, Oncobiologics hopes partnership with hospital services firm Premier will generate 'best practices around the optimal use of these cost-effective treatments.'